Cargando…

The stability of blood Eosinophils in chronic obstructive pulmonary disease

Blood eosinophils are a predictive biomarker of inhaled corticosteroid response in chronic obstructive pulmonary disease (COPD). We investigated blood eosinophil stability over 1 year using the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2019 thresholds of < 100, 100- < 300 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Gabriella H., Southworth, Thomas, Kolsum, Umme, Donaldson, Gavin C., Wedzicha, Jadwiga A., Brightling, Christopher E., Singh, Dave
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954589/ https://www.ncbi.nlm.nih.gov/pubmed/31924207 http://dx.doi.org/10.1186/s12931-020-1279-4

Ejemplares similares

Type 2 inflammation in eosinophilic chronic obstructive pulmonary disease
por: Higham, Andrew, et al.
Publicado: (2020)

Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patients
por: Lawrence, Philip J., et al.
Publicado: (2017)

Blood and sputum eosinophils in COPD; relationship with bacterial load
por: Kolsum, Umme, et al.
Publicado: (2017)

Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma
por: Kolsum, Umme, et al.
Publicado: (2017)

Bacteria and sputum inflammatory cell counts; a COPD cohort analysis
por: Beech, Augusta S., et al.
Publicado: (2020)

Daily activity during stability and exacerbation of chronic obstructive pulmonary disease
por: Alahmari, Ayedh D, et al.
Publicado: (2014)

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
por: Wedzicha, Jadwiga A, et al.
Publicado: (2013)

The relationship between airway immunoglobulin activity and eosinophils in COPD
por: Southworth, Thomas, et al.
Publicado: (2020)

Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
por: Singh, Dave, et al.
Publicado: (2020)

Inflammatory Endotype–associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis
por: Wang, Zhang, et al.
Publicado: (2021)

Airway host-microbiome interactions in chronic obstructive pulmonary disease
por: Wang, Zhang, et al.
Publicado: (2019)

Management of Exacerbations in Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2012)

25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease
por: Quint, Jennifer K, et al.
Publicado: (2012)

Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study
por: Hurst, John R, et al.
Publicado: (2010)

Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2008)

Acute exacerbations of chronic obstructive pulmonary disease: treatment and prevention
por: Seemungal, Terence, et al.
Publicado: (2008)

Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
por: Singh, Dave
Publicado: (2020)

Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease
por: Brill, Simon E, et al.
Publicado: (2014)

Causes of Death in Smokers: Implications for Chronic Obstructive Pulmonary Disease Management across Disease Severity
por: Wedzicha, Jadwiga A.
Publicado: (2023)

Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations
por: Ritchie, Andrew I., et al.
Publicado: (2020)

Factors Influencing the Stability of Blood Eosinophils Counts in Chronic Obstructive Pulmonary Disease Patients
por: Cai, Cheng-Sen, et al.
Publicado: (2022)

Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review
por: Hurst, John R, et al.
Publicado: (2009)

Inflammatory thresholds and the species-specific effects of colonising bacteria in stable chronic obstructive pulmonary disease
por: Singh, Richa, et al.
Publicado: (2014)

Leukotriene B4 levels in sputum from asthma patients
por: Higham, Andrew, et al.
Publicado: (2016)

Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease
por: Higham, Andrew, et al.
Publicado: (2022)

Measurement of Blood Eosinophils in Asthma and Chronic Obstructive Pulmonary Disease
por: Hirano, Tsunahiko, et al.
Publicado: (2022)

Re: Elevated Peripheral Blood Eosinophils during Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and clinical significance
por: Okauchi, Shinichiro, et al.
Publicado: (2022)

Eosinophilic Chronic Obstructive Pulmonary Disease
por: Weissler, Jonathan C., et al.
Publicado: (2021)

Clinical Predictors of High Blood Eosinophils in Chronic Obstructive Pulmonary Disease
por: Yang, Mei, et al.
Publicado: (2021)

Blood eosinophils in chronic obstructive pulmonary disease: A potential biomarker
por: Cui, Yanan, et al.
Publicado: (2023)

The stability of blood eosinophils in stable chronic obstructive pulmonary disease: a retrospective study in Belgian primary care
por: Van Rossem, Inès, et al.
Publicado: (2020)

The causes and consequences of seasonal variation in COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2014)

Deprivation, winter season, and COPD exacerbations
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Bronchiectasis, the Latest Eosinophilic Airway Disease: What about the Microbiome?
por: Singh, Dave, et al.
Publicado: (2022)

Type‐2 airway inflammation in mild asthma patients with high blood eosinophils and high fractional exhaled nitric oxide
por: Southworth, Thomas, et al.
Publicado: (2021)

Serial blood eosinophils and clinical outcome in patients with chronic obstructive pulmonary disease
por: Shin, Sun Hye, et al.
Publicado: (2018)

Blood Eosinophil Endotypes across Asthma and Chronic Obstructive Pulmonary Disease (COPD)
por: Luo, Jia-Ying, et al.
Publicado: (2022)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Acute Exacerbations
por: Wedzicha, J.A., et al.
Publicado: (2006)

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
por: Singh, Dave, et al.
Publicado: (2020)

Reply to Wang and Lai: The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Han, MeiLan K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7gfbllkchditq5ot0h2qht527a